Anti-proliferative effects of T cells expressing a ligand-based chimeric antigen receptor against CD116 on CD34+ cells of juvenile myelomonocytic leukemia-Reference-Cited by-同舟云学术

Anti-proliferative effects of T cells expressing a ligand-based chimeric antigen receptor against CD116 on CD34+ cells of juvenile myelomonocytic leukemia

Published:2016-03-16 Issue:1 Volume:9 Page:
ISSN:1756-8722
Container-title:Journal of Hematology & Oncology
language:en
Short-container-title:J Hematol Oncol

Author:

Nakazawa Yozo,Matsuda Kazuyuki,Kurata Takashi,Sueki Akane,Tanaka Miyuki,Sakashita Kazuo,Imai Chihaya,Wilson Matthew H.,Koike Kenichi

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Biology,Hematology

Link

http://link.springer.com/content/pdf/10.1186/s13045-016-0256-3

Reference30 articles.

1. Koike K, Matsuda K. Recent advances in the pathogenesis and management of juvenile myelomonocytic leukemia. Br J Haematol. 2008;141:567–75.

2. Dvorak CC, Loh ML. Juvenile myelomonocytic leukemia: molecular pathogenesis informs current approaches to therapy and hematopoietic cell transplantation. Front Pediatr. 2014;2:1–8.

3. Sakaguchi H, Okuno Y, Muramatsu H, Yoshida K, Shiraishi Y, Takahashi M, et al. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. Nat Genet. 2013;45:937–41.

4. Matsuda K, Nakazawa Y, Iwashita C, Kurata T, Hirabayashi K, Saito S, et al. Myeloid progenitors with PTPN11 and nonRAS pathway gene mutations are refractory to treatment with 6-mercaptopurine in juvenile myelomonocytic leukemia. Leukemia. 2014;287:1545–8.

5. Stieglitz E, Troup CB, Gelston LC, Haliburton J, Chow ED, Yu KB, et al. Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia. Blood. 2015;125:516–24.

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR-T cell therapy in AML: recent progress and future perspectives;International Journal of Hematology;2024-07-04

2. Identification of cancer-specific cell surface targets for CAR-T cell therapy;Inflammation and Regeneration;2024-03-29

3. Fine-Tuning through Generations: Advances in Structure and Production of CAR-T Therapy;Cancers;2023-07-03

4. piggyBac-transposon-mediated CAR-T cells for the treatment of hematological and solid malignancies;International Journal of Clinical Oncology;2023-03-02

5. Gene Therapy and Cardiovascular Diseases;Advances in Experimental Medicine and Biology;2022-12-02